Metropolitan Life Insurance CO Vor Biopharma Inc. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$3.09 - $5.33 $6,785 - $11,704	2,196 New	2,196 $6,000
Q1 2022 May 12, 2022	SELL	$6.04 - $12.23 $37,780 - $76,498	-6,255 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$11.32 - $18.02 $70,806 - $112,715	6,255 New	6,255 $72,000
Q3 2021 Jun 21, 2023	BUY	$12.24 - $20.38 $76,561 - $127,476	6,255 New	6,255 $98,000
Q3 2021 Mar 30, 2023	BUY	$12.24 - $20.38 $27,160 - $45,223	2,219 Added 54.98%	6,255 $98,000
Q3 2021 Nov 15, 2021	BUY	$12.24 - $20.38 $76,561 - $127,476	6,255 New	6,255 $98,000
Q2 2021 Aug 16, 2021	SELL	$18.65 - $38.78 $74 - $155	-4 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$30.96 - $54.08 $124,954 - $218,266	4,036 New	4,036 $174 Million
Q1 2021 Mar 30, 2023	BUY	$30.96 - $54.08 $124,954 - $218,266	4,036 New	4,036 $173,000
Q1 2021 May 14, 2021	BUY	$30.96 - $54.08 $123 - $216	4 New	4 $174,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.